Ansell Ltd (ASX: ANN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ansell Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.14 billion
P/E Ratio 20.04
Dividend Yield 1.93%
Shares Outstanding 128.01 million
Earnings per share 1.520
Dividend per share 0.80
Year To Date Return 20.27%
Earnings Yield 4.99%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

Ansell Ltd (ASX: ANN)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
22 Feb 2021 $0.4190 0.00% Interim 10 Mar 2021
31 Aug 2020 $0.3811 0.00% Final 17 Sep 2020
24 Feb 2020 $0.3288 0.00% Interim 12 Mar 2020
16 Aug 2019 $0.3833 0.00% Final 05 Sep 2019
22 Feb 2019 $0.5830 50.17% Interim 14 Mar 2019
24 Aug 2018 $0.3414 0.00% Final 13 Sep 2018
16 Feb 2018 $0.2588 44.13% Interim 08 Mar 2018
18 Aug 2017 $0.2998 0.00% Final 08 Sep 2017
17 Feb 2017 $0.2638 0.00% Interim 10 Mar 2017
19 Aug 2016 $0.3097 0.00% Final 08 Sep 2016
11 Feb 2016 $0.2795 0.00% Interim 10 Mar 2016
13 Aug 2015 $0.3119 0.00% Final 10 Sep 2015
12 Feb 2015 $0.2567 0.00% Interim 11 Mar 2015
28 Aug 2014 $0.2357 0.00% 24 Sep 2014
26 Feb 2014 $0.1828 0.00% Interim 25 Mar 2014
16 Feb 2012 $0.1500 0.00% Interim 14 Mar 2012
17 Feb 2011 $0.1400 0.00% Interim 16 Mar 2011
31 Aug 2010 $0.1750 0.00% Final 29 Sep 2010
11 Mar 2005 $0.0700 57.14% 08 Apr 2005

ANN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Ansell Ltd

Ansell Limited (ASX: ANN) is a global leader in health and safety protection solutions. The company operates in two main business segments, healthcare and industrial, to provide a range of personal protective equipment and safety devices.

Starting out from humble beginnings as a condom manufacturer in the early 1900s, Ansell is now known for primarily manufacturing a range of gloves using different materials for varying uses. With this, the company manufactures more than 10 billion gloves per year and protects more than 10 million people each day. Ansell provides protection solutions to more than 25 industries and has customers in over 100 countries across the globe.

In 1969, Ansell was acquired by Pacific Dunlop, an Australian conglomerate that was once one of the largest companies in the country. However, after selling and spinning off most of its businesses, Pacific Dunlop was renamed Ansell in 2002. Since then, the Ansell share price has gone from strength to strength, delivering capital gains to many shareholders over the years as well as income in the form of dividends.

ANN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
28 Jul 2021 $40.13 $-0.43 -1.06% 439,828 $40.84 $40.84 $39.93
27 Jul 2021 $40.56 $-0.85 -2.05% 583,165 $41.36 $41.36 $40.40
26 Jul 2021 $41.41 $0.28 0.68% 425,675 $41.28 $41.59 $41.13
23 Jul 2021 $41.13 $0.27 0.66% 199,703 $41.06 $41.44 $40.94
22 Jul 2021 $40.86 $-0.23 -0.56% 343,304 $41.40 $41.67 $40.66
21 Jul 2021 $41.09 $0.06 0.15% 414,986 $41.15 $41.36 $40.75
20 Jul 2021 $41.03 $0.94 2.34% 659,860 $40.20 $41.25 $40.19
19 Jul 2021 $40.09 $0.46 1.16% 357,888 $39.63 $40.40 $39.34
16 Jul 2021 $39.63 $0.23 0.58% 531,806 $39.40 $39.77 $39.20
15 Jul 2021 $39.40 $-0.97 -2.40% 908,477 $40.41 $40.62 $39.20
14 Jul 2021 $40.37 $-0.48 -1.18% 431,355 $40.85 $40.85 $39.81
13 Jul 2021 $40.85 $0.08 0.20% 260,718 $40.98 $41.20 $40.68
12 Jul 2021 $40.77 $-0.37 -0.90% 258,381 $41.38 $41.43 $40.64
09 Jul 2021 $41.14 $-0.28 -0.68% 481,522 $41.27 $41.33 $40.57
08 Jul 2021 $41.42 $0.56 1.37% 283,171 $40.99 $41.70 $40.95
07 Jul 2021 $40.86 $0.70 1.74% 368,415 $40.44 $41.12 $40.17
06 Jul 2021 $40.16 $-1.12 -2.71% 330,436 $41.28 $41.45 $40.08
05 Jul 2021 $41.28 $-0.34 -0.82% 235,183 $41.67 $41.90 $41.20
02 Jul 2021 $41.62 $-0.56 -1.33% 330,931 $42.20 $42.37 $41.37
01 Jul 2021 $42.18 $-1.33 -3.06% 432,461 $43.43 $43.43 $42.10
30 Jun 2021 $43.51 $0.15 0.35% 512,481 $43.51 $44.07 $43.40
29 Jun 2021 $43.36 $0.39 0.91% 449,705 $43.18 $43.43 $42.64

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
30 Jun 2021 John Bevan Buy 144 $6,324
Participation in share purchase plan.
30 Jun 2021 Leslie Desjardins Buy 78 $3,425
Participation in share purchase plan.
30 Jun 2021 Christina Stercken Buy 70 $3,074
Participation in share purchase plan.
30 Jun 2021 Christine Yan Buy 104 $4,567
Participation in share purchase plan.
31 May 2021 Christine Yan Buy 110 $4,541
Participation in share purchase plan.
31 May 2021 Christina Stercken Buy 73 $3,013
Participation in share purchase plan.
31 May 2021 Leslie Desjardins Buy 83 $3,426
Participation in share purchase plan.
31 May 2021 John Bevan Buy 153 $6,316
Participation in share purchase plan.
30 Apr 2021 John Bevan Buy 152 $6,423
Participation in share purchase plan.
30 Apr 2021 Leslie Desjardins Buy 83 $3,507
Participation in share purchase plan.
30 Apr 2021 Christine Yan Buy 110 $4,648
Participation in share purchase plan.
30 Apr 2021 Christina Stercken Buy 74 $3,127
Participation in share purchase plan.
31 Mar 2021 Christine Yan Buy 114 $4,520
Participation in share purchase plan.
31 Mar 2021 Christina Stercken Buy 76 $3,013
Participation in share purchase plan.
31 Mar 2021 John Bevan Buy 159 $6,304
Participation in share purchase plan.
31 Mar 2021 Leslie Desjardins Buy 86 $3,409
Participation in share purchase plan.
19 Mar 2021 Christina Stercken Buy 800 $29,600
On-market trade.
26 Feb 2021 Christina Stercken Buy 86 $3,108
Participation in share purchase plan.
26 Feb 2021 Christine Yan Buy 129 $4,662
Participation in share purchase plan.
26 Feb 2021 Leslie Desjardins Buy 97 $3,505
Participation in share purchase plan.
26 Feb 2021 John Bevan Buy 178 $6,432
Participation in share purchase plan.
18 Feb 2021 John Bevan Buy 157 $6,305
Participation in share purchase plan.
18 Feb 2021 Leslie Desjardins Buy 84 $3,373
Participation in share purchase plan.
18 Feb 2021 Christine Yan Buy 113 $4,538
Participation in share purchase plan.
18 Feb 2021 Christina Stercken Buy 75 $3,012
Participation in share purchase plan.
21 Jan 2021 Magnus Nicolin Transfer 80 $2,923,200
As advised by the company. 80,000 ordinary shares transferred from
Mr. Nicolin's "direct" shareholding to his "indirect" shareholding (held by
Skandinaviska Enskilda Banken on behalf
of Magnus R Nicolin and Sofie Nicolin)
21 Jan 2021 Magnus Nicolin Transfer 80 $2,923,200
As advised by the company. 80,000 ordinary shares transferred from
Mr. Nicolin's "direct" shareholding to his "indirect" shareholding (held by
Skandinaviska Enskilda Banken on behalf
of Magnus R Nicolin and Sofie Nicolin)
As per announcement on 27/01/2021.
31 Dec 2020 Leslie Desjardins Buy 103 $3,617
Participation in share purchase plan.
31 Dec 2020 John Bevan Buy 188 $6,602
Participation in share purchase plan.
31 Dec 2020 Christina Stercken Buy 90 $3,160
Participation in share purchase plan.
31 Dec 2020 Christine Yan Buy 136 $4,776
Participation in share purchase plan.
30 Dec 2020 Magnus Nicolin Issued 80 $2,843,864
Issue of securities. 286,165 - performance share rights
08 Dec 2020 William Reilly Sell 7 $260,025
On-market trade.
30 Nov 2020 John Bevan Buy 182 $6,825
Participation in share purchase plan.
30 Nov 2020 Leslie Desjardins Buy 98 $3,675
Participation in share purchase plan.
30 Nov 2020 Christine Yan Buy 132 $4,950
Participation in share purchase plan.
30 Nov 2020 Christina Stercken Buy 88 $3,300
Participation in share purchase plan.
24 Nov 2020 Nigel Garrard Buy 650 $24,180
On-market trade.
12 Nov 2020 Magnus Nicolin Sell 80 $3,178,949
On-market trade.
30 Oct 2020 Leslie Desjardins Buy 91 $3,721
Participation in share purchase plan.
30 Oct 2020 John Bevan Buy 168 $6,871
Participation in share purchase plan.
30 Oct 2020 Christina Stercken Buy 81 $3,312
Participation in share purchase plan.
30 Oct 2020 Christine Yan Buy 121 $4,948
Participation in share purchase plan.
09 Oct 2020 Magnus Nicolin Issued 19 $685,020
Issue of securities.
30 Sep 2020 Leslie Desjardins Buy 97 $3,642
Participation in share purchase plan.
30 Sep 2020 John Bevan Buy 179 $6,721
Participation in share purchase plan.
30 Sep 2020 Christine Yan Buy 129 $4,843
Participation in share purchase plan.
30 Sep 2020 Christina Stercken Buy 86 $3,229
Participation in share purchase plan.
22 Sep 2020 Nigel Garrard Buy 500 $17,825
On-market trade.
21 Sep 2020 Nigel Garrard Buy 1 $36,850
On-market trade.
01 Sep 2020 John Bevan Buy 181 $6,791
Participation in share purchase plan.
01 Sep 2020 Magnus Nicolin Issued 129 $4,381,205
Conversion of securities.
01 Sep 2020 Magnus Nicolin Exercise 116 $4,381,205
Conversion of securities. 205,488 - performance share rights
01 Sep 2020 Magnus Nicolin Sell 56 $1,923,349
On-market trade.
01 Sep 2020 Leslie Desjardins Buy 99 $3,714
Participation in share purchase plan.
01 Sep 2020 Christina Stercken Buy 86 $3,226
Participation in share purchase plan.
01 Sep 2020 Christine Yan Buy 124 $5,096
Participation in share purchase plan.
01 Sep 2020 Christine Yan Buy 130 $4,877
Participation in share purchase plan.
27 Aug 2020 Christina Stercken Buy 83 $3,411
Participation in share purchase plan.
27 Aug 2020 Leslie Desjardins Buy 92 $3,781
Participation in share purchase plan.
27 Aug 2020 John Bevan Buy 171 $7,027
Participation in share purchase plan.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr William Peter Day Non-Executive Director Aug 2007
Mr Day was formerly Chief Financial Officer of Amcor Limited for seven years, and Chief Financial Officer and Executive Director Finance of Bonlac Foods Limited. He also has held senior office and executive positions in the Australian Securities and Investments Commission (Deputy Chair), Rio Tinto, CRA and Comalco. He is also involved with disability services and education initiatives. He has a background in finance and general management across international industries. He is Chairman of Alumina Limited (2018 to present, Director since 2014), and Chairman of Australian Unity Investment Real Estate Limited (2015 to present). He is Chair of the Sustainability & Risk Committee and member of the Audit & Compliance Committee, Governance Committee and Share Buyback Sub-Committee.
Mr Nigel David Garrard Non-Executive Director Mar 2020
Mr Garrard is an experienced executive with a record across FMCG and Industrial/Manufacturing sectors. Mr Garrard has 20 years' experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr. Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Prior, Mr Garrard was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division and Managing Director of SPC Ardmona. Mr Garrard brings international experience across listed, not-for-profit, government and private entities. He is Chairman of McMahon Services (2019 to present), Non-executive Director of Hudson Institute of Medical Research (2016 to present). He is Member of the Sustainability & Risk Committee, Human Resources Committee and Share Buyback Sub-Committee.
Mr William G Reilly Non-Executive Director Oct 2017
Mr Reilly has over 35 years' experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. Prior to joining Ansell, Mr Reilly held senior legal positions at C. R. Bard, Inc., The Hertz Corporation and McKesson Corporation. He is Member of the Sustainability & Risk Committee, the Human Resources Committee, the Governance Committee and M&A Sub-Committee.
Ms Marissa T Peterson Non-Executive Director Aug 2006
Mrs Peterson currently runs Mission Peak Executive Consulting. Mrs Peterson retired from full-time executive roles in 2006, having spent 18 years with Sun Microsystems as Executive Vice President of Services, Executive Vice President of Worldwide Operations, and as Chief Customer Advocate. She has experience in supply chain management, manufacturing and quality, logistics, information technologies, customer advocacy and leadership development. She is Director of Humana Inc. (2008 to present). She is Chair of the Human Resources Committee and member of Compliance Committee.
Mr John Andrew Bevan Non-Executive DirectorNon-Executive Chairman Aug 2012
Mr Bevan was formerly the Chief Executive Officer and Executive Director of Alumina Limited and brings to the Board international business experience. Prior to joining Alumina Limited, he had a career with the BOC Group Plc, where he was a member of the Board of Directors and held a variety of senior management positions in Australia, Korea, Thailand, Singapore and the UK. He is Chairman of BlueScope Steel Limited (2014 to present), Non-executive Director of Humpty Dumpty Foundation (2017 to present) and Alumina Limited (2018 to present). He is Chair of the Governance Committee and Share Buyback Sub-Committee and member of the Human Resources Committee and the M&A Sub-Committee.
Mr Magnus Ranae Nicolin Chief Executive OfficerManaging Director Mar 2010
Mr Nicolin spent three years with Newell Rubbermaid Inc., most recently as President, Europe, Middle East, Africa and Asia Pacific. Prior to that he spent seven years with Esselte Business Systems Inc, where in 2002 he led the leveraged buy-out of Esselte from the Stockholm and London Stock Exchanges. Following the buy-out he became the Chief Executive Officer of Esselte. Mr Nicolin has also held senior management positions with Bayer AG, Pitney Bowes and McKinsey & Company.
Ms Leslie A Desjardins Non-Executive Director Nov 2015
Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the US and Australia, including Chief Financial Officer GM Holden, Controller for GM North America, and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is Non-executive Director and Audit & Risk Committee Chair of ALS Limited (2019 to present), Non-executive Director and Audit Committee Chair of Terry Fox Cancer Foundation (2018 to present). She is Chair of the Compliance Committee and member of the Sustainability & Risk Committee, M&A Sub-Committee and Share Buyback Sub-Committee.
Mrs Christina Stercken Non-Executive Director Oct 2017
Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. In her function as Vice Chairman of Myanmar Foundation, Munich, Mrs Stercken supports social projects in Myanmar. She is Director of Landis & Gyr Group AG (2017 to present), Myanmar Foundation (Vice Chairman). She is Member of the Compliance Committee and Sustainability & Risk Committee, Chair of the M&A Sub-Committee.
Ms Christine Yingli Yan Non-Executive Director Feb 2019
Ms Yan is an experienced executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings a range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation and marketing in the business- to- business industry. She is Non-executive Director of ON Semiconductor Corporation (2018 to present), Non-executive Director of Modine Manufacturing Company Inc. (2014 to present) and Non-executive Director of Cabot Corporation (2019 to present). She is Member of the Compliance Committee and the Human Resources Committee.
Ms Catherine Stribley Company Secretary Apr 2017
-
Mr Martin Evans Joint Company Secretary Apr 2021
-
Renae Leary Chief Commercial Officer - Americas
-
Rikard Froberg Chief Commercial Officer - EMEA & APAC
-
Zubair Javeed Chief Financial Officer - Finance IT Planning & Projects
-
Amanda Manzoni Chief Human Resources Officer
-
Catherine Stribley Company Secretary
-
Michael Gilleece Corporate General Counsel
-
Deanna Johnston Global Chief Information Officer
-
Martin Evans Joint Company Secretary
-
Darryl Nazareth President of the Healthcare GBU
-
Neil Salmon President of the Industrial GBU
-
Angie Phillips SBU Vice President & GM HGBU Surgical & HSS
-
Augusto Accorsi SBU Vice President & GM HGBU Exam & Single Use
-
Paul Bryce SBU Vice President & GM IGBU Chemical Solutions
-
Sean Sweeney SBU Vice President & GM IGBU Mechanical Solutions
-
Francois le Jeune Senior Vice President - Business Development Transformation and Corporate Marketing
-
John Marsden Senior Vice President - Global Operations and Global Supply Chain
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
FISBC Custody Nominees (Australia) Limited 44,026,364 34.25%
J P Morgan Nominees Australia Pty Limited 24,865,868 19.35%
Citicorp Nominees Pty Limited 14,915,214 11.60%
National Nominees Limited 5,569,511 4.33%
BNP Paribas Nominees Pty Ltd 1,967,225 1.53%
HOC Custody Nominees (Australia) Limited 1,551,036 1.21%
BNP Paribas Noms Pty Ltd 1,333,941 1.04%
Australian Foundation Investment Company Limited 1,078,865 0.84%
National Nominees Limited (I) 631,739 0.49%
Netwealth Investments Limited 505,005 0.39%
Australian Executor Trustees Limited 353,090 0.27%
Citicorp Nominees Pty Limited (I) 339,147 0.26%
Argo Investments Limited 336,972 0.26%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Sery Ltd 303,180 0.24%
Amp Life Limited 300,031 0.23%
Australian Executor Trustees Limited (I) 299,229 0.23%
HOC Custody Nominees (Australia) Limited NC 2 296,274 0.23%
Cs Fourth Nominees Pty Limited 240,062 0.19%
The Manly Hotels Pty Limited 222,854 0.17%
HOC Custody Nominees (Australia) Limited GSCO ECA 197,602 0.15%

Frequently Asked Questions

Ansell’s most recent dividend payment was an interim dividend of 32.88 cents in March 2020, which was unfranked. Thus far, it has not made any announcements regarding further dividend payments in 2020.

Yes, Ansell offers a dividend reinvestment plan (DRP) as an alternative to receiving cash dividends on Ansell ordinary shares.

Profile

since

Note